statistiche ricercatore

Continente	#
NA - Nord America	536
AS - Asia	258
EU - Europa	216
SA - Sud America	53
Continente sconosciuto - Info sul continente non disponibili	14
AF - Africa	10
OC - Oceania	1
Totale	1.088

Nazione	#
US - Stati Uniti d'America	513
SG - Singapore	104
CN - Cina	65
IT - Italia	47
BR - Brasile	39
DE - Germania	34
HK - Hong Kong	34
UA - Ucraina	27
FI - Finlandia	21
GB - Regno Unito	20
CA - Canada	15
VN - Vietnam	13
RU - Federazione Russa	12
FR - Francia	11
IE - Irlanda	9
NL - Olanda	9
BD - Bangladesh	8
TR - Turchia	8
IN - India	7
ES - Italia	5
AR - Argentina	4
BE - Belgio	4
JP - Giappone	4
MX - Messico	4
SE - Svezia	4
ZA - Sudafrica	4
LT - Lituania	3
PK - Pakistan	3
PL - Polonia	3
AT - Austria	2
CL - Cile	2
CR - Costa Rica	2
EC - Ecuador	2
EG - Egitto	2
SA - Arabia Saudita	2
VE - Venezuela	2
AE - Emirati Arabi Uniti	1
AL - Albania	1
AM - Armenia	1
AU - Australia	1
CO - Colombia	1
CY - Cipro	1
DZ - Algeria	1
ET - Etiopia	1
EU - Europa	1
GE - Georgia	1
GY - Guiana	1
ID - Indonesia	1
IQ - Iraq	1
KE - Kenya	1
KR - Corea	1
KZ - Kazakistan	1
LV - Lettonia	1
MD - Moldavia	1
PA - Panama	1
PE - Perù	1
PH - Filippine	1
PT - Portogallo	1
SK - Slovacchia (Repubblica Slovacca)	1
SV - El Salvador	1
TN - Tunisia	1
UY - Uruguay	1
UZ - Uzbekistan	1
Totale	1.075

Nome	#
Cohort profile: Standardized management of antiretroviral therapy cohort (MASTER cohort)	227
Long-term efficacy of dolutegravir in treatment-experienced subjects failing therapy with HIV-1 integrase strand inhibitor-resistant virus	167
Low-level viraemia, measured as viraemia copy-years, as a prognostic factor for medium-long-term all-cause mortality: A MASTER cohort study	161
Burden of Disease in PWH Harboring a Multidrug-Resistant Virus: Data from the PRESTIGIO Registry	125
Cervical human papillomavirus infection and shedding of human immunodeficiency virus in cervicovaginal fluids: A cross-sectional study	94
Differential diagnosis of cervical mycobacterial lymphadenitis in children	89
Efficacy, Convenience, Safety and Durability of DTG-Based Antiretroviral Therapies: Evidence from a Prospective Study by the Italian MaSTER Cohort	71
Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO Registry	65
Polypharmacy, anticholinergic burden and drug-drug interaction assessment in people with four-class-resistant HIV: data from the PRESTIGIO registry	62
All-Cause Mortality in People with Four-Class Drug-Resistant HIV: A Matched Cohort Analysis with Data from the PRESTIGIO Registry	27
Totale	1.088

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	47	0	9	3	2	1	4	3	3	3	4	4	11
2022/2023	65	11	0	1	7	8	14	0	3	12	0	3	6
2023/2024	61	4	3	10	6	8	13	1	1	8	0	0	7
2024/2025	198	0	3	0	16	19	25	18	11	15	27	38	26
2025/2026	448	42	52	33	69	55	21	58	9	36	47	20	6
2026/2027	15	6	9	0	0	0	0	0	0	0	0	0	0
Totale													1.088